Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

Fluphenazine and iloprost can induce hair growth.

Chemotherapy damages hair follicles, causing hair loss and other cellular changes.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Two new compounds were found that could promote hair growth as well or better than minoxidil.

The treatment combination is effective and generally safe for lung cancer.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Activating certain hair follicle cells could prevent hair loss from cancer treatments.

Chemotherapy causes permanent hair follicle damage by triggering stem cell loss.

Nonimmunosuppressive cyclosporines might treat skin diseases by affecting cell growth.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

High levels of ODC and a mutant Ha-ras gene cause tumors in mice.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.